John Trainer
Chief Operating Officer at IMMUNOCORE HOLDINGS PLC
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| John Bell | M | 71 | 9 years | |
| Robert Perez | M | 59 | 5 years | |
| Grant Verstandig | M | 34 | 3 years | |
| Yoshifumi Torii | M | 57 |
Fujifilm Kyowa Kirin Biologics Co., Ltd.
 Fujifilm Kyowa Kirin Biologics Co., Ltd. BiotechnologyHealth Technology Fujifilm Kyowa Kirin Biologics Co., Ltd. is a Japanese company that is not well described by the given metadata. The joint venture company is based in Tokyo, Japan. However, based on the company name, it is likely that they are involved in the biotechnology or pharmaceutical industry. The company was founded in 2012. The CEO is Yoshifumi Torii. | - |
| Madhav Devalaraja | M | 59 |
Corvidia Therapeutics, Inc.
 Corvidia Therapeutics, Inc. BiotechnologyHealth Technology Corvidia Therapeutics, Inc. is a biotechnology company focusing on cardiovascular therapies. It develops treatments for atherosclerotic cardiovascular disease, inflammation in chronic kidney diseases, and high triglyceride-induced acute pancreatitis. The company was founded by Michael H. Davidson, Rahul Kakkar, Matt Devalaraja, and Ram Aiyar in 2015 and is headquartered in Waltham, MA. | 9 years |
| Travis Coy | M | - | 5 years | |
| Roy Herbst | M | 60 | 3 years | |
| Kristine Peterson | F | 64 | 7 years | |
| Lily Hepworth | F | - | 6 years | |
| Peter Ratcliffe | M | 69 | - | |
| Bahija Jallal | M | 62 | 5 years | |
| Mitsuhiro Sato | M | 64 |
Fujifilm Kyowa Kirin Biologics Co., Ltd.
Fujifilm Kyowa Kirin Biologics Co., Ltd. BiotechnologyHealth Technology Fujifilm Kyowa Kirin Biologics Co., Ltd. is a Japanese company that is not well described by the given metadata. The joint venture company is based in Tokyo, Japan. However, based on the company name, it is likely that they are involved in the biotechnology or pharmaceutical industry. The company was founded in 2012. The CEO is Yoshifumi Torii. | - |
| Leena Gandhi | M | 53 | 2 years | |
| Siddharth Kaul | M | - | 2 years | |
| Chad Rubin | M | - | 3 years | |
| Ralph Torbay | M | - | 3 years | |
| Hoyeol Yoon | M | 61 |
Archigen Biotech Ltd.
 Archigen Biotech Ltd. Pharmaceuticals: MajorHealth Technology Archigen Biotech Ltd. is a British company that develops, manufactures, and distributes biological pharmaceuticals. Archigen Biotech is based in Cambridge, UK. The joint venture company was founded in 2014. | - |
| Tae Han Kim | M | 67 |
Archigen Biotech Ltd.
Archigen Biotech Ltd. Pharmaceuticals: MajorHealth Technology Archigen Biotech Ltd. is a British company that develops, manufactures, and distributes biological pharmaceuticals. Archigen Biotech is based in Cambridge, UK. The joint venture company was founded in 2014. | - |
| Alex Wilkes | M | 45 |
Archigen Biotech Ltd.
Archigen Biotech Ltd. Pharmaceuticals: MajorHealth Technology Archigen Biotech Ltd. is a British company that develops, manufactures, and distributes biological pharmaceuticals. Archigen Biotech is based in Cambridge, UK. The joint venture company was founded in 2014. | - |
| Karl David Bradshaw | M | 50 |
Archigen Biotech Ltd.
Archigen Biotech Ltd. Pharmaceuticals: MajorHealth Technology Archigen Biotech Ltd. is a British company that develops, manufactures, and distributes biological pharmaceuticals. Archigen Biotech is based in Cambridge, UK. The joint venture company was founded in 2014. | - |
| Mohammed Dar | M | - | 5 years | |
| Sylvie Grégoire | M | 63 |
Corvidia Therapeutics, Inc.
Corvidia Therapeutics, Inc. BiotechnologyHealth Technology Corvidia Therapeutics, Inc. is a biotechnology company focusing on cardiovascular therapies. It develops treatments for atherosclerotic cardiovascular disease, inflammation in chronic kidney diseases, and high triglyceride-induced acute pancreatitis. The company was founded by Michael H. Davidson, Rahul Kakkar, Matt Devalaraja, and Ram Aiyar in 2015 and is headquartered in Waltham, MA. | 8 years |
| Graziano Seghezzi | M | 55 |
Corvidia Therapeutics, Inc.
Corvidia Therapeutics, Inc. BiotechnologyHealth Technology Corvidia Therapeutics, Inc. is a biotechnology company focusing on cardiovascular therapies. It develops treatments for atherosclerotic cardiovascular disease, inflammation in chronic kidney diseases, and high triglyceride-induced acute pancreatitis. The company was founded by Michael H. Davidson, Rahul Kakkar, Matt Devalaraja, and Ram Aiyar in 2015 and is headquartered in Waltham, MA. | - |
| David Berman | M | - | 5 years | |
| Tyrell J. Rivers | M | 51 |
Corvidia Therapeutics, Inc.
Corvidia Therapeutics, Inc. BiotechnologyHealth Technology Corvidia Therapeutics, Inc. is a biotechnology company focusing on cardiovascular therapies. It develops treatments for atherosclerotic cardiovascular disease, inflammation in chronic kidney diseases, and high triglyceride-induced acute pancreatitis. The company was founded by Michael H. Davidson, Rahul Kakkar, Matt Devalaraja, and Ram Aiyar in 2015 and is headquartered in Waltham, MA. | - |
| Alexander G. Asam | M | 58 |
Corvidia Therapeutics, Inc.
Corvidia Therapeutics, Inc. BiotechnologyHealth Technology Corvidia Therapeutics, Inc. is a biotechnology company focusing on cardiovascular therapies. It develops treatments for atherosclerotic cardiovascular disease, inflammation in chronic kidney diseases, and high triglyceride-induced acute pancreatitis. The company was founded by Michael H. Davidson, Rahul Kakkar, Matt Devalaraja, and Ram Aiyar in 2015 and is headquartered in Waltham, MA. | - |
| Patrick Yang | M | 75 |
Archigen Biotech Ltd.
Archigen Biotech Ltd. Pharmaceuticals: MajorHealth Technology Archigen Biotech Ltd. is a British company that develops, manufactures, and distributes biological pharmaceuticals. Archigen Biotech is based in Cambridge, UK. The joint venture company was founded in 2014. | - |
| John Goll | M | - | 1 years | |
| Paul Eisenberg | M | - |
Corvidia Therapeutics, Inc.
Corvidia Therapeutics, Inc. BiotechnologyHealth Technology Corvidia Therapeutics, Inc. is a biotechnology company focusing on cardiovascular therapies. It develops treatments for atherosclerotic cardiovascular disease, inflammation in chronic kidney diseases, and high triglyceride-induced acute pancreatitis. The company was founded by Michael H. Davidson, Rahul Kakkar, Matt Devalaraja, and Ram Aiyar in 2015 and is headquartered in Waltham, MA. | - |
| Brian DiDonato | M | 57 | 4 years | |
| Matthew Schiller | M | - | 3 years | |
| Tina St. Leger | F | 56 | 2 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Scott Carmer | M | 59 | 8 years | |
| Alain D. Cappeluti | M | - | - | |
| Tim Stover | M | - | 3 years | |
| Jerome Zeldis | M | 74 | 2 years | |
| Robert Knight | M | 73 | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United Kingdom | 20 | 54.05% |
| United States | 15 | 40.54% |
| Japan | 2 | 5.41% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- John Trainer
- Personal Network
